Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study

INTRODUCTION: Atopic dermatitis (AD) can require long-term therapy. Few real-world studies have evaluated long-term effectiveness from the patients’ perspective. The aim of this study was to evaluate patient-reported outcomes (PROs) during long-term dupilumab treatment. METHODS: Adults with moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimball, Alexa B., Delevry, Dimittri, Yang, Min, Chuang, Chien-Chia, Wang, Zhixiao, Bégo-Le-Bagousse, Gaëlle, Martins, Bruno, Wu, Eric, Shumel, Brad, Wang, Jessie, Sierka, Debra, Chao, Jingdong, Strober, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442302/
https://www.ncbi.nlm.nih.gov/pubmed/37552431
http://dx.doi.org/10.1007/s13555-023-00965-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442302/
https://www.ncbi.nlm.nih.gov/pubmed/37552431
http://dx.doi.org/10.1007/s13555-023-00965-5

Ejemplares similares